Strategies for streamlined analytical method development for ADC molecules
Samsung Biologics’ platform analytical development strategy accelerates method development timelines by applying core platform methods across a wide range of ADC molecules.
By reducing iteration and streamlining method transfer through optimization at the start of the project, Samsung Biologics meets clients’ expedited analytical timeline needs without compromising performance:
- Applicability to a wide range of ADC molecules and linker-payloads
- Test scope encompasses both “platform-able” and less “platform-able” methods
- Cell-based assay method development shortened by 1.5 months
Samsung Biologics’ platform analytical development strategy accelerates method development timelines by applying core platform methods across a wide range of ADC molecules.
By reducing iteration and streamlining method transfer through optimization at the start of the project, Samsung Biologics meets clients’ expedited analytical timeline needs without compromising performance:
- Applicability to a wide range of ADC molecules and linker-payloads
- Test scope encompasses both “platform-able” and less “platform-able” methods
- Cell-based assay method development shortened by 1.5 months
Related Content